“The Belgian Federal Government is committed to making Belgium a real health and biotech valley in which biopharmaceutical research, development and production in our country are stimulated.”
Alexander de Croo
Belgium Prime Minister
Bringing all stakeholders together
On 20 September 2022, PwC hosted a ground-breaking event that saw all stakeholders in the healthcare sector come together to discuss their ideas of what their industry could and should look like in the years to come - and how they could best collectively achieve their ambitions. This is the first time in Belgium that leaders of government, pharma, biotech, hospitals and other key stakeholders sat together to consider the future in such a holistic way. We’ll be holding this event annually to enable ongoing discussion, collaboration and co-creation to the benefits of patients and citizens.
Our speakers
Thomas Solbach
Partner and Future of Health expert, Strategy& Germany, PwC
Benoit Collin
Managing Director, INAMI/RIZIV
Paul d'Otreppe
President, BVZD/ABDH
Caroline Ven
Chief Executive Officer, Pharma.be
Sylvie Ponchaut
Managing Director, Biowin
Wouter Piepers
Chief Executive Officer, Flanders Bio
Elena Bonfiglioli
Global General Manager Healthcare Industry, Microsoft
< Back
< Back
[+] Read More
.jpeg)
What does the future of healthcare look like?
Our eminent panellists considered a number of pertinent questions with regards to Belgian healthcare in the future, including what will tomorrow’s patient’s needs be and how can we reach their expectations? Will R&D speed up and what will the impact of data be? How can greater collaboration be fostered? What will the new value pools be? And much more. You can access a wrap-up of the discussion by clicking on the banner below.
Michele Paque
Connect with PwC Belgium
